Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) Dividend Payout Ratio: 0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920433 Inner Mongolia Grand Pharmaceutical Co Ltd BJSE:920433
70 GF Score
Price ¥4.94
GF Value ¥3.89
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Inner Mongolia Grand Pharmaceutical Co Dividend Payout Ratio?

Inner Mongolia Grand Pharmaceutical Co BJSE:920433 70 Dividend Payout Ratio is 0.00 as of Jun. 2026. GuruFocus rates BJSE:920433 with a GF Score™ of 70/100 and a GF Value™ of ¥3.89 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 447 Drug Manufacturers companies, Inner Mongolia Grand Pharmaceutical Co ranks worse than 223713.42% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio for the months ended in Jun. 2026 was 0.00.

The historical rank and industry rank for Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:


During the past 13 years, the highest Dividend Payout Ratio of Inner Mongolia Grand Pharmaceutical Co was 10.20. The lowest was 0.54. And the median was 1.63.

BJSE:920433's Dividend Payout Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.38
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2026-09-04), the Dividend Yield % of Inner Mongolia Grand Pharmaceutical Co is 0.00%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Inner Mongolia Grand Pharmaceutical Co was 15.20%. The lowest was 0.00%. And the median was 2.12%.

Inner Mongolia Grand Pharmaceutical Co's Dividends per Share for the months ended in Jun. 2026 was ¥0.00.

During the past 12 months, Inner Mongolia Grand Pharmaceutical Co's average Dividends Per Share Growth Rate was -100.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -50.70% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Inner Mongolia Grand Pharmaceutical Co was -28.80% per year. The lowest was -50.70% per year. And the median was -39.75% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Inner Mongolia Grand Pharmaceutical Co Dividend Payout Ratio Related Terms


Inner Mongolia Grand Pharmaceutical Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inner Mongolia Grand Pharmaceutical Co Dividend Payout Ratio Chart

Inner Mongolia Grand Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 10.20 0.00 1.63 0.00

Inner Mongolia Grand Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BJSE:920433 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inner Mongolia Grand Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio falls into.


BJSE:920433
70GF Score
Inner Mongolia Grand Pharmaceutical Co Ltd BJSE:920433
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inner Mongolia Grand Pharmaceutical Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=0.06/ -0.278
=N/A

Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=0/ -0.041
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) has a Dividend Payout Ratio of 0.00 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Inner Mongolia Grand Pharmaceutical Co and its competitors. Over the past decade, Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.54 to 10.20. According to the industry distribution chart, Inner Mongolia Grand Pharmaceutical Co ranks #999999 out of 447 companies in the Drug Manufacturers industry.
Is Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio too high?
Inner Mongolia Grand Pharmaceutical Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 10.20. Based on the distribution chart, Inner Mongolia Grand Pharmaceutical Co ranks #999999 out of 447 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Inner Mongolia Grand Pharmaceutical Co has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Inner Mongolia Grand Pharmaceutical Co's Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Inner Mongolia Grand Pharmaceutical Co ranks #999999 out of 447 companies for Dividend Payout Ratio. This places Inner Mongolia Grand Pharmaceutical Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Inner Mongolia Grand Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.54 to 10.20 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 447 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Inner Mongolia Grand Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inner Mongolia Grand Pharmaceutical Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inner Mongolia Grand Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥3.89, compared to a current price of ¥4.94 — trading 27% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Inner Mongolia Grand Pharmaceutical Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Inner Mongolia Grand Pharmaceutical Co (BJSE:920433), the current Dividend Payout Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inner Mongolia Grand Pharmaceutical Co (BJSE:920433) Overvalued in 2026?

Based on GuruFocus' analysis, Inner Mongolia Grand Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥4.94 is trading 27% above its estimated GF Value™ of ¥3.89. GuruFocus considers Inner Mongolia Grand Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for BJSE:920433:

  • Dividend Payout Ratio: 0.00
  • GF Value™: ¥3.89 vs. price of ¥4.94 (27% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the BJSE:920433 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Inner Mongolia Grand Pharmaceutical Co Business Description

Address Wuwei Road, 2nd Floor, Administration Building, Ruyi Development Zone, Inner Mongolia Autonomous Region, Hohhot, CHN, 010010
Inner Mongolia Grand Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating the development of Mongolian medicine resources. It engages in the research and development, production, and sales of specialty medicines and general health products. The company's main business is the research and development, production of Chinese patent medicines (including ethnic medicines) and chemical preparations, and sales.
70GF Score

Get the complete analysis for BJSE:920433

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.94
Price
¥3.89
GF Value